Possible explanations for the results of CRASH. (Record no. 15331866)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01232 a2200325 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514214252.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200502s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-547X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S0140-6736(05)17733-2 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kasperlik-Zaluska, Anna A |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20050203 |
| 245 00 - TITLE STATEMENT | |
| Title | Possible explanations for the results of CRASH. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Lancet (London, England) |
| Date of publication, distribution, etc. | |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 212-3; author reply 213-214 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Comment; Letter |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Craniocerebral Trauma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glucocorticoids |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hypothalamo-Hypophyseal System |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infusions, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Methylprednisolone |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pituitary-Adrenal System |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Rate |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Slowi'nska-Srzednicka, Jadwiga |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bonicki, Wieslaw |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kunicki, Jacek |
| 773 0# - HOST ITEM ENTRY | |
| Title | Lancet (London, England) |
| Related parts | vol. 365 |
| -- | no. 9455 |
| -- | p. 212-3; author reply 213-214 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S0140-6736(05)17733-2">https://doi.org/10.1016/S0140-6736(05)17733-2</a> |
| Public note | Available from publisher's website |
No items available.